Thus, the development of novel small molecules targeting the upstream regulators, such as PKCε and cytoplasmic deacetylases that promote the nuclear translocation of HDAC6, may provide an opportunity to prevent the metastasis of lung cancer. Here, HDAC6 is linked to lung carcinoma.